XNPT just got significantly more risky with the FDA insider trading news and SEC charges. Lots of April options and straddles at risk if FDA decides to extend or delay a decision due to this. They could potentially get wiped out. For the risk-averse FDA and its lawyers, might be the prudent thing to do until they can ensure no advance trading has occurred on this one. April options holders might want to lighten up on their positions or go to longer dated options.